Finance

Beta
Lists
IMVT:NASDAQ
Immunovant Inc
$31.11
-4.78%
(-1.56) 1D
$30.74
-1.19% (-0.37)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMVT...
Open
$32.48
High
$32.88
Low
$30.78
Mkt. cap
6.39B
Avg. vol.
2.22M
Volume
872.08K
52-wk high
$36.28
52-wk low
$14.32
EPS
-$2.77
Beta
0.76
Shares outstanding
205.31M
No. of employees
315
Open
$32.48
High
$32.88
Low
$30.78
Mkt. cap
6.39B
Avg. vol.
2.22M
Volume
872.08K
52-wk high
$36.28
52-wk low
$14.32
EPS
-$2.77
Beta
0.76
Shares outstanding
205.31M
No. of employees
315
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to IMVT in the past 3 months
Strong Buy
Buy
10
Hold
3
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for IMVT in the last 3 months.
Highest
Current $31.11
$66.00 (+112.15%)
Average
$44.92 (+44.39%)
Lowest
$28.00 (-10.00%)
News stories
From sources across the web
About Immunovant Inc
CEO-
Employees315
Founded2018
Headquarters-
SectorBiotechnology
Websiteimmunovant.com
Last report
May 20, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
-$0.73 / -$0.62
-18.09%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
101.20M
114.25M
98.92M
142.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.02M
17.51M
15.44M
17.27M
Operating expense
127.22M
131.76M
114.36M
159.55M
Total operating expenses
127.22M
131.76M
114.36M
159.55M
Operating income
-127.22M
-131.76M
-114.36M
-159.55M
Other non operating income
1.19M
250.00K
-54.00K
798.00K
EBT including unusual items
-119.70M
-125.91M
-109.08M
-150.70M
EBT excluding unusual items
-119.70M
-125.91M
-109.08M
-150.70M
Income tax expense
913.00K
594.00K
1.55M
-2.84M
Effective tax rate
-0.76%
-0.47%
-1.42%
1.89%
Other operating expenses
-
-
-
-
Net income
-120.61M
-126.50M
-110.64M
-147.86M
Net profit margin
-
-
-
-
Earnings per share
-0.71
-0.65
-0.54
-0.67
Interest and investment income
6.34M
5.60M
5.33M
8.06M
Interest expense
-
-
-
-
Net interest expenses
6.34M
5.60M
5.33M
8.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-127.12M
-131.66M
-114.26M
-159.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer